Russell Investments Group, Ltd. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$234,000
-31.6%
99,139
-17.5%
0.00%0.0%
Q2 2022$342,000
-31.2%
120,099
-30.5%
0.00%0.0%
Q1 2022$497,000
+69.6%
172,732
+78.2%
0.00%
Q4 2021$293,000
-88.5%
96,921
-73.3%
0.00%
-100.0%
Q3 2021$2,540,000
+1932.0%
362,671
+2545.7%
0.00%
Q2 2021$125,000
-89.8%
13,708
-89.4%
0.00%
-100.0%
Q1 2021$1,228,000
-18.5%
129,429
-11.3%
0.00%
-33.3%
Q4 2020$1,506,000
-20.0%
145,908
-22.1%
0.00%
-25.0%
Q3 2020$1,882,000
+33.0%
187,401
+35.8%
0.00%
+33.3%
Q2 2020$1,415,000
+127.1%
138,041
+86.7%
0.00%
+50.0%
Q1 2020$623,000
-7.0%
73,932
-4.3%
0.00%
+100.0%
Q4 2019$670,000
+86.1%
77,275
+139.9%
0.00%0.0%
Q3 2019$360,000
+54.5%
32,215
+181.1%
0.00%0.0%
Q4 2018$233,000
-53.2%
11,460
+5.4%
0.00%0.0%
Q3 2018$498,000
-41.3%
10,872
-24.3%
0.00%
-50.0%
Q2 2018$849,000
-27.0%
14,356
-16.0%
0.00%0.0%
Q1 2018$1,163,000
-30.4%
17,084
+2.0%
0.00%
-33.3%
Q4 2017$1,671,000
-46.0%
16,743
-35.1%
0.00%
-40.0%
Q3 2017$3,092,000
+52.6%
25,817
+11.4%
0.01%
+25.0%
Q2 2017$2,026,000
+2010.4%
23,182
+640.4%
0.00%
Q4 2016$96,0003,1310.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders